Loading
Magnified skin imaging and whole-body photo mapping, increasingly read by algorithms, to find melanoma early and avoid unnecessary biopsies.
Dermoscopy improves diagnostic accuracy over the naked eye; sequential total-body photography tracks change in high-risk patients. Deep-learning classifiers have matched dermatologists on benchmark images and DermaSensor (elastic scattering spectroscopy, FDA 2024) is cleared for primary care. Real-world impact depends on population, skin tone representation in training data, and workflow; no screening RCT has shown mortality benefit.
Polarised or immersion magnification of skin structures; convolutional networks trained on labelled lesion images; spectroscopy of tissue optical properties.
Query for this technology: (TITLE:"Dermoscopy, total-body photography & AI skin analysis" OR ABSTRACT:"Dermoscopy, total-body photography & AI skin analysis") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Dermoscopy, total-body photography & AI skin analysis, not a curated reading list.
Shares Breslow thickness, Bowen's disease (squamous cell carcinoma in situ), Stage IIB and IIC melanoma, Acral melanoma.
Shares Breslow thickness, Stage IIB and IIC melanoma, Acral melanoma, Melanoma.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Basal cell carcinoma, Skin cancer (all types), Melanoma.
Shares Bowen's disease (squamous cell carcinoma in situ), Cutaneous squamous cell carcinoma, Basal cell carcinoma, Skin cancer (all types).
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma, Skin cancer (all types), Melanoma.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Cutaneous squamous cell carcinoma, Basal cell carcinoma, Skin cancer (all types).
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Basal cell carcinoma, Skin cancer (all types).
Shares Bowen's disease (squamous cell carcinoma in situ), Cutaneous squamous cell carcinoma, Basal cell carcinoma, Skin cancer (all types).
Commercial and regulated products that serve this technology. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
An electrical impedance spectroscopy device with a classifier that scores a suspicious skin lesion before the decision to excise.
A handheld spectroscopy device with an algorithm that tells a primary care clinician whether a skin lesion should be referred.
A smartphone application that assesses a photograph of a skin lesion and tells the user whether to see a doctor.